Stay updated on Tiragolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab in Lung Cancer Clinical Trial page.
Latest updates to the Tiragolumab in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedLocations list updated with many new sites across the United States, Australia, Europe, and Latin America, and several sites removed. Revision tag updated to v3.3.3.SummaryDifference1%
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe study location list expanded to 132 sites worldwide, adding new entries such as Gdańsk and HOCH Health Ostschweiz, and removing several previous sites. Dates were updated to 2025-12-05 and 2025-12, and the primary completion date is now 2026-01-31.SummaryDifference0.7%
- Check33 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2 on the study page; no study details, endpoints, eligibility criteria, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check40 days agoChange DetectedThe page no longer displays the government funding/operating status notice banner for the NIH Clinical Center. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check47 days agoChange DetectedThe Taiwan site entry in the Locations list was updated: 'Tainan City, Taiwan, 704' was removed and replaced with 'Tainan, Taiwan, 704'.SummaryDifference0.0%
- Check54 days agoChange DetectedThe page appears largely unchanged; any differences are limited to formatting or styling rather than study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
Stay in the know with updates to Tiragolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab in Lung Cancer Clinical Trial page.